Concepedia

Kate J. Newberry

KJ

Statistics

Publications

40

Citations

4.8K

H-Index

29

Active since

1997

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Institut Gustave Roussy

Oregon Health & Science University

University of California, Santa Barbara

Memorial Sloan Kettering Cancer Center

Kate J. Newberry is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

1997–2023

40

Publications

40

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Simon Rule, Peter Martin et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

Michael Wang, Luis Fayad, Nicolaus A. Wagner‐Bartak et al. · The Lancet Oncology · 2012 · 296 citations

, , +8

Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms

Masoud Vedadi, J. Lew, J.D. Artz et al. · Molecular and Biochemical Parasitology · 2006 · 235 citations

, , +10

Clonal evolution and outcomes in myelofibrosis after ruxolitinib discontinuation

Kate J. Newberry, Keyur P. Patel, Lucia Masárová et al. · Blood · 2017 · 210 citations · Full text

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial

M Wang, Nathan Fowler, Nicolaus A. Wagner‐Bartak et al. · Leukemia · 2013 · 203 citations

, , +6

1–5 of 40